Quarterly report pursuant to Section 13 or 15(d)

2. Summary of Significant Accounting Policies (Details Narrative)

v3.20.2
2. Summary of Significant Accounting Policies (Details Narrative) - USD ($)
3 Months Ended 6 Months Ended
Jun. 30, 2020
Jun. 30, 2019
Jun. 30, 2020
Jun. 30, 2019
Mar. 31, 2020
Dec. 31, 2019
Mar. 31, 2019
Dec. 31, 2018
Net loss $ (841,000) $ (1,458,000) $ (1,607,000) $ (3,740,000)        
Cash flow from operations     (787,000) (1,833,000)        
Stockholders' deficit (3,015,000) (1,524,000) (3,015,000) (1,524,000) $ (2,599,000) $ (2,269,000) $ (989,000) $ (1,482,000)
Cash on Hand 116,000 711,000 116,000 711,000   $ 479,000   $ 1,153,000
Research and development costs 157,000 432,000 227,000 583,000        
Operating expenses $ 413,000 $ 655,000 945,000 1,133,000        
Patent Costs [Member]                
Operating expenses     $ 13,000 $ 9,000